Additional file 7: Table S6. NC P/LP carrier count/frequency of all affected genes, ASE NC P/LPs enriched genes and genes impacted by NC P/LPs across different quartile expression splits.
IntroductionBreast cancer patients with germline pathogenic variants may benefit from risk-reducing surgeries, intensive screening, and targeted cancer therapies. There is a paucity of data regarding
Panel sequencing of susceptibility genes for hereditary breast and ovarian cancer (HBOC) syndrome has uncovered numerous germline variants; however, their pathogenic relevance and ethnic diversity rem
